334792-76-6 Usage
General Description
3-Bromo-2-fluorobenzoic acid ethyl ester is a chemical compound with the molecular formula C9H8BrFO2. It is a white to off-white crystalline solid that is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 3-BROMO-2-FLUOROBENZOIC ACID ETHYL ESTER is a derivative of benzoic acid and contains both bromine and fluorine atoms, which impart unique chemical and physical properties. It is mainly used in organic synthesis processes as a reagent and building block for the production of various chemical compounds. 3-Bromo-2-fluorobenzoic acid ethyl ester is considered to be a hazardous substance and should be handled with caution due to its potential health and environmental risks.
Check Digit Verification of cas no
The CAS Registry Mumber 334792-76-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,4,7,9 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 334792-76:
(8*3)+(7*3)+(6*4)+(5*7)+(4*9)+(3*2)+(2*7)+(1*6)=166
166 % 10 = 6
So 334792-76-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H8BrFO2/c1-2-13-9(12)6-4-3-5-7(10)8(6)11/h3-5H,2H2,1H3
334792-76-6Relevant articles and documents
AUTOTAXIN INHIBITORS AND USES THEREOF
-
Paragraph 00324; 00329, (2016/12/22)
Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.
AUTOTAXIN INHIBITOR COMPOUNDS
-
Page/Page column 00305; 00343, (2015/06/08)
Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorde
COMPOUND HAVING 6-MEMBERED AROMATIC RING
-
Page/Page column 48, (2010/12/17)
An object of the present invention is to provide an agent for preventing or treating schizophrenia or the like, wherein the compound of the present invention has GPR52 agonist activity. [Means] A compound represented by the following formula (I) or salt t
